Concepedia

M Rinaldi-Carmona

MR

13

Publications

2.2K

Citations

13

H-Index

1992

Active since

Affiliations

Sanofi (France)(Current)

M Rinaldi-Carmona is an author at Sanofi (France) specializing in pharmacology, medicine, and neuropharmacology.

Top concepts

Publications per year

1992–2002

13

Publications

13

SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor

M Rinaldi-Carmona, Francis Barth, J Millan et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 704 citations · Full text

Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1

Monsif Bouaboula, Caroline Poinot‐Chazel, B. Bourrié et al. · Biochemical Journal · 1995 · 537 citations · Full text

Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716

Jean-Paul Terranova, Jean-Jacques Storme, N. Lafon et al. · Psychopharmacology · 1996 · 286 citations

, , +11

Characterization of two cloned human CB1 cannabinoid receptor isoforms.

M Rinaldi-Carmona, Bernard Calandra, David Shire et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 121 citations

Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonist.

M Rinaldi-Carmona, Christian Congy, Vincent Santucci et al. · Journal of Pharmacology and Experimental Therapeutics · 1992 · 116 citations · Full text

Rows per page

1–5 of 13